Enalapril

renin ; Homo sapiens







114 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34740310 Topical Administration of ACE Inhibitor Interrupts the Progression of Cataract in Two Kidney One Clip Induced Hypertensive Cataract Model. 2022 Mar 1
2 31531687 ARNIs: balancing "the good and the bad" of neuroendocrine response to HF. 2020 May 1
3 32049647 A continued method performance monitoring approach for the determination of pediatric renin samples - application within a European clinical trial. 2020 Oct 25 1
4 33130795 [Hypertensive crisis in a 3-year-old boy - neurovascular conflict?] 2020 Oct 23 1
5 28356668 Targeting renin-angiotensin system in malignant hypertension in atypical hemolytic uremic syndrome. 2017 Mar-Apr 1
6 28534088 The PPAR-gamma-binding sequence Pal3 is necessary for basal but dispensable for high-fat diet regulated human renin expression in the kidney. 2017 Oct 2
7 24667808 A transgenic platform for testing drugs intended for reversal of cardiac remodeling identifies a novel 11βHSD1 inhibitor rescuing hypertrophy independently of re-vascularization. 2014 1
8 24788577 Simultaneous quantitative and qualitative analysis of aliskiren, enalapril and its active metabolite enalaprilat in undiluted human urine utilizing LC-ESI-MS/MS. 2014 Dec 1
9 24958603 Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE? 2014 Aug 3
10 23052033 Pharmacokinetics, pharmacodynamics, and tolerability of ACT-077825, a new direct renin inhibitor after multiple-ascending doses in healthy subjects. 2013 Jan 2
11 23404365 A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine Renin-Angiotensin-aldosterone system. 2013 1
12 21393355 Characterization of a stable, hypertensive rat model suitable for the consecutive evaluation of human renin inhibitors. 2011 Sep 1
13 21424707 cAMP target sequences enhCRE and CNRE sense low-salt intake to increase human renin gene expression in vivo. 2011 May 1
14 21576655 Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. 2011 May 31 1
15 17222813 Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms. 2007 Feb 1
16 16685219 Renin increments the inward calcium current in the failing heart. 2006 Jun 1
17 15772526 Changes in plasma lipids during renin-angiotensin system blockade by combination therapy (enalapril plus valsartan) in patients with diabetes and hypertension. 2005 Apr 1
18 16227143 Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors. 2005 Oct 1
19 15589004 Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure. 2004 Dec 15 1
20 11877580 Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis. 2002 Mar 1
21 11288044 The effects of angiotensin-II on lipolysis in humans. 2001 Apr 2
22 10717928 [Ednit effects on activity of renin-angiotensin-aldosterone system and renal function in hypertensive subjects with diabetes mellitus]. 2000 1
23 11078175 Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. 2000 Nov 1
24 10193670 Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers. 1999 Mar 1
25 10216807 Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group. 1999 1
26 10496190 Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. 1999 Sep 1
27 8960618 Effects of enalapril on the exercise capacity and neurohumoral factors during exercise in patients with chronic heart failure. 1997 Jan-Feb 1
28 9040450 Additive effects of losartan and enalapril on blood pressure and plasma active renin. 1997 Feb 2
29 9247766 Pharmacological demonstration of the additive effects of angiotensin-converting enzyme inhibition and angiotensin II antagonism in sodium depleted healthy subjects. 1997 Jul-Aug 1
30 8549037 Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men. 1996 Jan 1
31 8777826 Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man. 1996 Mar 1
32 8859935 Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure. 1996 May 1
33 8986921 Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies. 1996 Dec 1
34 7843751 Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. 1995 Jan 1
35 8682064 Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use. 1995 Dec 2
36 7858555 Comparative and combined efficacy of doxazosin and enalapril in hypertensive patients. 1994 Nov 1
37 7889195 Role of the renin-angiotensin system in hypertension in the elderly. 1994 1
38 8061844 Angiotensin-converting enzyme inhibitors and effects on left ventricular hypertrophy. 1994 1
39 8205752 Effects of angiotensin-converting enzyme inhibition on renal dysfunction induced by moderate potassium depletion in healthy women. 1994 Mar 1
40 7903825 Hyperrenin-hyperaldosterone-dependent malignant hypertension in polyarteritis nodosa. 1993 Dec 1
41 7910063 Blood pressure response to angiotensin converting enzyme inhibitor in essential hypertension: its relation to the renin status and natriuresis during acute sodium loading. 1993 Nov 3
42 8500237 Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group. 1993 Jun 1
43 8510084 Regression of vascular structural changes and calcium metabolism in patients with essential hypertension after long-term monotherapy with enalapril. 1993 Apr 1
44 1337459 Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system. 1992 Dec 1
45 1637731 Enalapril versus combined enalapril and nadolol treatment: effects on blood pressure, heart rate, humoral variables, and plasma potassium at rest and during exercise in hypertensive patients. 1992 Jun 1
46 1662562 Different hemodynamic (24-h ambulatory blood pressure monitoring) and renin-inhibiting effect of a 1-week treatment with enalapril and lisinopril. 1991 Nov 1
47 1679372 Enalapril in congestive heart failure: acute hemodynamic and neurohumoral evaluation and short-term follow-up. 1991 Jul 1
48 1680982 Comparison of enalapril and conventional vasodilator therapy in patients with chronic congestive heart failure. 1991 May 2
49 1901528 Prevention of nitrate tolerance with angiotension converting enzyme inhibitors. 1991 Apr 1
50 1915427 Comparison of hormonal and haemodynamic changes after long-term oral therapy with pimobendan or enalapril--a double-blind randomized study. 1991 Aug 1